TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17.83%8.8B | 38.39%23.21B | 20.89%7.47B | 3.46%16.77B | 14.09%6.18B | 19.95%16.21B | 16.22%5.42B | 10.88%13.52B | 5.07%4.66B | 17.40%12.19B |
Operating income | 17.83%8.8B | 38.39%23.21B | 20.89%7.47B | 3.46%16.77B | 14.09%6.18B | 19.95%16.21B | 16.22%5.42B | 10.88%13.52B | 5.07%4.66B | 17.40%12.19B |
Cost of sales | -18.05%-4.41B | -37.98%-9.38B | -20.92%-3.74B | -4.97%-6.8B | -15.83%-3.09B | -15.81%-6.48B | -9.66%-2.67B | -2.01%-5.59B | 2.91%-2.43B | -12.57%-5.48B |
Operating expenses | -18.05%-4.41B | -37.98%-9.38B | -20.92%-3.74B | -4.97%-6.8B | -15.83%-3.09B | -15.81%-6.48B | -9.66%-2.67B | -2.01%-5.59B | 2.91%-2.43B | -12.57%-5.48B |
Gross profit | 17.62%4.39B | 38.67%13.83B | 20.86%3.73B | 2.45%9.98B | 12.40%3.09B | 22.88%9.74B | 23.39%2.75B | 18.12%7.92B | 15.43%2.23B | 21.68%6.71B |
Selling expenses | -12.07%-2.27B | -31.52%-8.06B | -25.06%-2.03B | 0.75%-6.12B | -0.56%-1.62B | -28.37%-6.17B | -33.51%-1.61B | -12.41%-4.81B | -8.04%-1.21B | -24.32%-4.28B |
Administrative expenses | -31.95%-768.59M | -25.24%-1.51B | -10.94%-582.48M | -0.07%-1.2B | -15.95%-525.06M | -17.24%-1.2B | -16.01%-452.83M | -20.32%-1.03B | -16.26%-390.34M | -16.99%-852.96M |
Impairment and provision | ---70M | 40.68%-70M | ---- | -195.00%-118M | ---98M | 13.04%-40M | ---- | 53.06%-46M | ---- | -127.91%-98M |
-Goodwill impairment | ---70M | 40.68%-70M | ---- | -195.00%-118M | ---98M | 13.04%-40M | ---- | 53.06%-46M | ---- | -127.91%-98M |
Special items of operating profit | 76.53%194.02M | -33.73%196.97M | 7.51%109.91M | 20.81%297.21M | -9.82%102.23M | 36.71%246.01M | 195.70%113.37M | 53.23%179.95M | -24.64%38.34M | 69.78%117.44M |
Operating profit | 19.56%1.47B | 55.59%4.4B | 30.24%1.23B | 10.02%2.83B | 18.95%945.16M | 15.47%2.57B | 19.25%794.61M | 39.15%2.22B | 39.49%666.36M | 16.63%1.6B |
Financing income | 10.84%197.32M | 27.62%374.21M | -3.34%178.02M | -7.21%293.21M | 38.37%184.17M | 48.04%316M | 28.34%133.09M | 10.72%213.46M | -5.15%103.7M | 3.35%192.79M |
Financing cost | -9.27%-105.46M | -3.04%-216.36M | 16.11%-96.51M | -5.72%-209.98M | -10.87%-115.04M | -1.46%-198.61M | 15.19%-103.77M | -2.19%-195.75M | -21.36%-122.35M | -17.65%-191.56M |
Share of profits of associates | 56.32%-5.22M | 36.33%-14.2M | -68.60%-11.95M | -58.25%-22.3M | ---7.09M | ---14.09M | ---- | ---- | ---- | ---- |
Earning before tax | 19.83%1.56B | 57.28%4.54B | 29.12%1.3B | 8.05%2.89B | 22.24%1.01B | 19.17%2.67B | 27.21%823.93M | 40.15%2.24B | 33.21%647.72M | 14.73%1.6B |
Tax | -8.33%-416.37M | -94.42%-1.42B | -35.97%-384.35M | -19.17%-730.93M | -43.63%-282.67M | -14.15%-613.38M | -25.86%-196.8M | -32.80%-537.34M | -24.32%-156.36M | -4.04%-404.64M |
After-tax profit from continuing operations | 24.66%1.14B | 44.69%3.12B | 26.45%916.19M | 4.74%2.16B | 15.53%724.53M | 20.75%2.06B | 27.63%627.14M | 42.64%1.7B | 36.31%491.36M | 18.87%1.2B |
Earning after tax | 24.66%1.14B | 44.69%3.12B | 26.45%916.19M | 4.74%2.16B | 15.53%724.53M | 20.75%2.06B | 27.63%627.14M | 42.64%1.7B | 36.31%491.36M | 18.87%1.2B |
Minority profit | 604.89%12.38M | 158.66%46.06M | 74.87%-2.45M | 601.52%17.81M | 13.95%-9.76M | 22.80%-3.55M | -312.98%-11.34M | 41.83%-4.6M | -70.10%5.32M | -132.62%-7.91M |
Profit attributable to shareholders | 22.98%1.13B | 43.74%3.07B | 25.11%918.64M | 3.70%2.14B | 15.01%734.29M | 20.63%2.06B | 31.36%638.47M | 42.09%1.71B | 41.84%486.03M | 22.61%1.2B |
Basic earnings per share | 22.20%0.1035 | 43.49%0.2834 | 24.74%0.0847 | 3.19%0.1975 | 14.12%0.0679 | 19.77%0.1914 | 31.06%0.0595 | 41.79%0.1598 | 40.56%0.0454 | 20.92%0.1127 |
Diluted earnings per share | 21.32%0.1013 | 42.66%0.2752 | 23.89%0.0835 | 2.72%0.1929 | 14.63%0.0674 | 19.09%0.1878 | 30.38%0.0588 | 42.59%0.1577 | 41.38%0.0451 | 20.61%0.1106 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.